BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28701375)

  • 1. SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination.
    Wei R; Xu LW; Liu J; Li Y; Zhang P; Shan B; Lu X; Qian L; Wu Z; Dong K; Zhu H; Pan L; Yuan J; Pan H
    Genes Dev; 2017 Jun; 31(11):1162-1176. PubMed ID: 28701375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABIN-1 regulates RIPK1 activation by linking Met1 ubiquitylation with Lys63 deubiquitylation in TNF-RSC.
    Dziedzic SA; Su Z; Jean Barrett V; Najafov A; Mookhtiar AK; Amin P; Pan H; Sun L; Zhu H; Ma A; Abbott DW; Yuan J
    Nat Cell Biol; 2018 Jan; 20(1):58-68. PubMed ID: 29203883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPATA2 links CYLD to the TNF-α receptor signaling complex and modulates the receptor signaling outcomes.
    Wagner SA; Satpathy S; Beli P; Choudhary C
    EMBO J; 2016 Sep; 35(17):1868-84. PubMed ID: 27307491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis.
    Amin P; Florez M; Najafov A; Pan H; Geng J; Ofengeim D; Dziedzic SA; Wang H; Barrett VJ; Ito Y; LaVoie MJ; Yuan J
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E5944-E5953. PubMed ID: 29891719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners.
    Li X; Zhang M; Huang X; Liang W; Li G; Lu X; Li Y; Pan H; Shi L; Zhu H; Qian L; Shan B; Yuan J
    Nat Commun; 2020 Dec; 11(1):6364. PubMed ID: 33311474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PELI1 functions as a dual modulator of necroptosis and apoptosis by regulating ubiquitination of RIPK1 and mRNA levels of c-FLIP.
    Wang H; Meng H; Li X; Zhu K; Dong K; Mookhtiar AK; Wei H; Li Y; Sun SC; Yuan J
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):11944-11949. PubMed ID: 29078411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.
    Schlicher L; Wissler M; Preiss F; Brauns-Schubert P; Jakob C; Dumit V; Borner C; Dengjel J; Maurer U
    EMBO Rep; 2016 Oct; 17(10):1485-1497. PubMed ID: 27458237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2.
    Annibaldi A; Wicky John S; Vanden Berghe T; Swatek KN; Ruan J; Liccardi G; Bianchi K; Elliott PR; Choi SM; Van Coillie S; Bertin J; Wu H; Komander D; Vandenabeele P; Silke J; Meier P
    Mol Cell; 2018 Feb; 69(4):566-580.e5. PubMed ID: 29452637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.
    Elliott PR; Leske D; Hrdinka M; Bagola K; Fiil BK; McLaughlin SH; Wagstaff J; Volkmar N; Christianson JC; Kessler BM; Freund SM; Komander D; Gyrd-Hansen M
    Mol Cell; 2016 Sep; 63(6):990-1005. PubMed ID: 27591049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical contribution of oxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation.
    Shindo R; Kakehashi H; Okumura K; Kumagai Y; Nakano H
    Biochem Biophys Res Commun; 2013 Jun; 436(2):212-6. PubMed ID: 23727581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPATA2 restricts OTULIN-dependent LUBAC activity independently of CYLD.
    Griewahn L; Müller-Foxworth M; Peintner L; Wissler M; Weiss M; Brauns-Schubert P; Massoumi R; Borner C; Groß O; Yabal M; Charvet C; Maurer U
    Cell Rep; 2023 Jan; 42(1):111961. PubMed ID: 36640323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis.
    Geng J; Ito Y; Shi L; Amin P; Chu J; Ouchida AT; Mookhtiar AK; Zhao H; Xu D; Shan B; Najafov A; Gao G; Akira S; Yuan J
    Nat Commun; 2017 Aug; 8(1):359. PubMed ID: 28842570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear Ubiquitination of RIPK1 on Lys612 Regulates Systemic Inflammation via Preventing Cell Death.
    Tu H; Tang Y; Zhang J; Cheng L; Joo D; Zhao X; Lin X
    J Immunol; 2021 Jul; 207(2):602-612. PubMed ID: 34162724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo.
    Shutinoski B; Alturki NA; Rijal D; Bertin J; Gough PJ; Schlossmacher MG; Sad S
    Cell Death Differ; 2016 Oct; 23(10):1628-37. PubMed ID: 27258786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLEKHO2 inhibits TNFα-induced cell death by suppressing RIPK1 activation.
    Zhou C; Zhang X; Yang C; He Y; Zhang L
    Cell Death Dis; 2021 Jul; 12(8):714. PubMed ID: 34272357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis.
    Meng H; Liu Z; Li X; Wang H; Jin T; Wu G; Shan B; Christofferson DE; Qi C; Yu Q; Li Y; Yuan J
    Proc Natl Acad Sci U S A; 2018 Feb; 115(9):E2001-E2009. PubMed ID: 29440439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant and food additive BHA prevents TNF cytotoxicity by acting as a direct RIPK1 inhibitor.
    Delanghe T; Huyghe J; Lee S; Priem D; Van Coillie S; Gilbert B; Choi SM; Vandenabeele P; Degterev A; Cuny GD; Dondelinger Y; Bertrand MJM
    Cell Death Dis; 2021 Jul; 12(7):699. PubMed ID: 34262020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OTULIN limits cell death and inflammation by deubiquitinating LUBAC.
    Heger K; Wickliffe KE; Ndoja A; Zhang J; Murthy A; Dugger DL; Maltzman A; de Sousa E Melo F; Hung J; Zeng Y; Verschueren E; Kirkpatrick DS; Vucic D; Lee WP; Roose-Girma M; Newman RJ; Warming S; Hsiao YC; Kőműves LG; Webster JD; Newton K; Dixit VM
    Nature; 2018 Jul; 559(7712):120-124. PubMed ID: 29950720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB.
    Suda J; Dara L; Yang L; Aghajan M; Song Y; Kaplowitz N; Liu ZX
    J Immunol; 2016 Oct; 197(8):3120-3129. PubMed ID: 27605011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
    Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
    Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.